Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision
The DOI matches its Crossref record; 14 of the 16 references it cites were found in a registry or an index.
Abstract
Summary The cost-effectiveness of Fracture Liaison Services (FLSs) for prevention of secondary fracture in osteoporosis patients in the United Kingdom (UK), and the cost associated with their widespread adoption, were evaluated. An estimated 18 fractures were prevented and £21,000 saved per 1,000 patients. Setup across the UK would cost an estimated £9.7 million.Introduction Only 11% to 28% of patients with a fragility fracture receive osteoporosis treatment in the UK. FLSs provide an efficient means to identify patients and are endorsed by the Department of Health but have not been widely adopted. The objective of this study was to evaluate the cost-effectiveness of FLSs in the UK and the cost associated with their widespread adoption.Methods A cost-effectiveness and budget-impact model was developed, utilising detailed audit data collected by the West Glasgow FLS.Results For a hypothetical cohort of 1,000 fragility-fracture patients (740 requiring treatment), 686 received treatment in the FLS compared with 193 in usual care. Assessments and osteoporosis treatments cost an additional £83,598 and £206,544, respectively, in the FLS; 18 fractures (including 11 hip fractures) were prevented, giving an overall saving of £21,000. Setup costs for widespread adoption of FLSs across the UK were estimated at £9.7 million.Conclusions FLSs are cost-effective for the prevention of further fractures in fragility-fracture patients. The cost of widespread adoption of FLS across the UK is small in comparison with other service provision and would be expected to result in important benefits in fractures avoided and reduced hospital bed occupancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These programs have accomplished a reduction in secondary fracture rates as well as health care cost savings [98, 99].”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [99]
Citations
Cites
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052 · cited 1×
“[20].”
McLellan, A. R., Gallacher, S. J., Fraser, M., & McQuillian, C. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1507-z · Cited by 421
Self-citationWorld Health Statistics Quarterly
Beauchamp, G. R. (1985) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75890-8 · Cited by 338
Stevenson, M., Lloyd Jones, M., De Nigris, E., Brewer, N., Davis, S., & Oakley, J. (2005) · Health Technology Assessment · doi:10.3310/hta9220 · Cited by 295 · cited 1×
“Patients’ health-related quality of life (HRQL) was modelled over time using utility weights for patients with osteoporosis but no fracture [25].”
MethodTreatment of established osteoporosis: a systematic review and cost-utility analysis
Kanis, J. A., Brazier, J. E., Stevenson, M., Calvert, N. W., & Lloyd Jones, M. (2002) · Health Technology Assessment · doi:10.3310/hta6290 · Cited by 229 · cited 1×
“0 over a period of 5 years [23].”
BackgroundOsteoporosis Disease Management: The Role of the Orthopaedic Surgeon
Dell, R., Greene, D., Schelkun, S. R., & Williams, K. (2008) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.h.00628 · Cited by 165 · cited 2×
“Our results are broadly consistent with the findings of the Department of Health analysis for the UK [16] and the findings reported for similar services in Canada [12–14] and the USA [ 15 ].”
BackgroundResultInfluentialAn updated systematic review of Health State Utility Values for osteoporosis related conditions
Peasgood, T., Herrmann, K., Kanis, J. А., & Brazier, J. E. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0844-y · Cited by 132 · cited 3×
“[26] were unable to report a utility multiplier for humerus fracture as insufficient data were identified.”
BackgroundMethodInfluentialREFRACTURES IN PATIENTS AT LEAST FORTY-FIVE YEARS OLD
Robinson, C. M., Royds, M. T., ABRAHAM, A., McQueen, M. M., Court-Brown, C. M., & Christie, J. H. (2002) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200209000-00004 · Cited by 111
A Coordinator Program in Post-Fracture Osteoporosis Management Improves Outcomes and Saves Costs
Sander, B., Elliot-Gibson, V., Beaton, D. E., Bogoch, E. R., & Maetzel, A. (2008) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.g.00980 · Cited by 108 · cited 3×
“Our results are broadly consistent with the findings of the Department of Health analysis for the UK [16] and the findings reported for similar services in Canada [12–14] and the USA [15].”
BackgroundResult
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
“These programs have accomplished a reduction in secondary fracture rates as well as health care cost savings [98, 99].”
BackgroundCompston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Fragility fractures in Europe: burden, management and opportunities
for the International Osteoporosis Foundation, Borgström, F., Karlsson, L., Ortsäter, G., Norton, N., Halbout, P., Cooper, C., Lorentzon, M., McCloskey, E. V., Harvey, N. C., et al. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-0706-y · Cited by 797
IOF Fracture Working Group, Åkesson, K., Marsh, D., Mitchell, P. J., McLellan, A. R., Stenmark, J., Pierroz, D. D., Kyer, C., & Cooper, C. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2348-z · Cited by 521
Self-citation
Metadata
- Authors
- McLellan, A. R., Wolowacz, S. E., Zimovetz, E. A., Beard, S. M., Lock, S., McCrink, L., Adekunle, F., & Roberts, D.
- Affiliations
- Western Infirmary (GB)
- University of Manchester (GB)
- Novartis (United Kingdom) (GB)
- Corresponding author
- Wolowacz, S. E.
- Venue
- Osteoporosis International
- Published
- 2011-05-24
- Volume
- 22
- Issue
- 7
- Pages
- 2083-2098
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2009179975
- Cited by
- 255
- References
- 16
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 12 · 2023: 17 · 2022: 17 · 2021: 22 · 2020: 15 · 2019: 17 · 2018: 20 · 2017: 18 · 2016: 25 · 2015: 15 · 2014: 18 · 2013: 22 · 2012: 10
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novartis Pharmaceuticals UK Limited
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Hip and Femur Fractures
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- fracture liaison service, osteoporotic fractures, secondary fracture prevention, cost-effectiveness, budget impact, osteoporosis treatment, fragility fractures, hip fracture, hospital bed occupancy
- MeSH terms
- Aged, Aged, 80 and over, Cost-Benefit Analysis, Diphosphonates, Female, United Kingdom, Hip Fractures, Humans, Humeral Fractures, Male, Middle Aged, Osteoporosis, Quality of Life, Risk Factors, Wrist Injuries, Bone Density, Models, Economic, Dietary Supplements, Bone Density Conservation Agents, Secondary Prevention, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. https://app.cochat.ai/papers/10.1007/s00198-011-1534-0
- The paper
- McLellan, A. R., Wolowacz, S. E., Zimovetz, E. A., Beard, S. M., Lock, S., McCrink, L., Adekunle, F., & Roberts, D. (2011). Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporosis International. https://doi.org/10.1007/s00198-011-1534-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.